Corona Virus
The new coronavirus from Wuhan has caused severe breathing difficulties in China, which is known as COVID-19. A worldwide pandemic has since emerged from the clinical manifestation of coronavirus disease 2019 (COVID-19) caused by infection with SARS-CoV-2. The World Health Organisation issued this statement in April. As of October 22, 2020, there were at least 2.5 million confirmed cases of COVID-19. Identified in 213 countries with a minimum of 169000 patients. Passing away due to their disease or its aftereffects. Following the initial outbreak in China, transmission was identified. From respiratory droplets and fomites that initially show symptoms. Characterised by severe hypoxia (lack of oxygen in body tissues to carry oxygen), coughing, fever, and dyspnea (difficulty in breathing). More clinical experience has led to a greater variety of symptoms emerging. Such as gastrointestinal difficulties, headaches, or mental health problems. Anosmia (loss of smell) and severe confusion.
Stroke
The prevalence of stroke, a leading cause of death and disability, has significantly increased. About 60% of strokes are ischaemic strokes (IS), with intracerebral haemorrhages (ICH) accounting for 25% and subarachnoid haemorrhages (SAH) for roughly 10%. [expert_callback text="Get Free Online Consultation with Expert" buttontext=" Request a Callback" link="]
Research about COVID and Stroke
- Stroke is the most frequent brain issue among hospitalised COVID-19 patients. According to early reports, many COVID-19 patients experienced symptoms related to the brain, and severe cases frequently involved significant problems with blood flow in the brain. These issues became less frequent as more treatments became available. People who had a stroke before contracting COVID-19 are more likely to experience negative outcomes, such as an increased risk of hospital death.
- Even those who tested positive for COVID-19 but did not experience severe symptoms are twice as likely to experience heart issues in the future, according to a recent study. This implies that some people may suffer long-term harm from COVID-19.
- According to earlier studies, approximately 25% of hospitalised COVID-19 patients may experience cardiac problems, which can result in heart attacks, irregular heartbeats, heart failure, cardiac arrest, or strokes.
- According to research, a person's blood type may influence their response to COVID-19 and their risk of heart issues. Those with type O blood appear to be less likely than those with other blood types to contract COVID-19. However, compared to people with type O blood, those with type A or B blood are more likely to experience heart disease, heart attacks, blood clots, and strokes.
- According to a 2023 study, the virus was discovered in the arteries of COVID-19 fatalities. Heart attacks and strokes may result from the virus's ability to induce inflammation and release toxic chemicals. According to the study, the virus can infect the walls of the arteries and combine with pre-existing plaque to raise the risk of heart issues.
COVID-19 as a Risk Factor for Stroke
Young patients tend to have milder or asymptomatic COVID-19 infection, where the risk of stroke is lower. However, compared to young individuals without COVID-19 infection, those with COVID-19 infection tend to have a higher risk of developing stroke. In fact, recent research shows that stroke can be the first sign of COVID amongst patients below the age of 45 years. Younger people tend to have a more severe stroke due to large vessel involvement.
The following conditions were linked to worse outcomes:- Diabetes
- A blockage in the arteries
- People over 60 have a higher National Institutes of Health (NIH) score.
- A higher neutrophil-to-lymphocyte ratio, a gauge of inflammation and immunology, is indicative of a stroke.
Prevent Stroke after COVID-19
According to the study, medical professionals may adopt a different strategy for prevention for some patients if they are aware that a history of severe COVID-19 is a risk factor for cardiac problems. For instance, doctors may think about prophylactically administering drugs like aspirin to patients who have had significant COVID-19 to lower their risk of cardiac events. In fact, the study's initial sub-analysis revealed that severe COVID-19 patients who were already taking aspirin for other purposes had a lower risk of stroke. To determine if these preventative medications can directly lower the incidence of cardiac events or stroke in patients with severe COVID-19, the researchers believe additional direct investigations of the connection are required in the future, such as randomised clinical trials. In order to better understand what is happening in the arteries to raise a person's risk of stroke and Heart attack, they also intend to perform mechanistic studies and investigate additional genetic markers that may affect the link.
Know more about: Revolutionizing Stroke Treatment: From Tradition to Technology
Active
